Antivirals

Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ

amministratore — Thu, 10 Apr 2014 06:00:23 +0000

There is no good evidence about the effectiveness of Tamiflu (oseltamivir) and Relenza (zanamivir) for influenza prevention and treatment. This is the tough claim made by Cochrane Collaboration and the British Medical Journal (BMJ), based on the extended systematic review they just published about the use of neuraminidase inhibitors against influenza.

Their study is entirely based on complete clinical study reports, trial registries, electronic databases, regulatory archives and correspondence with manufacturers, which correspond to more than 150,000 pages of documents; more specifically, the

Tags:

Antiviral Therapies

Antivirals

Oseltamivir

zanamivir

Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ

amministratore — Thu, 10 Apr 2014 06:00:23 +0000

Tags:

Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ

amministratore — Thu, 10 Apr 2014 06:00:23 +0000

Tags:

Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ

amministratore — Thu, 10 Apr 2014 06:00:23 +0000

Tags:

Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ

amministratore — Thu, 10 Apr 2014 06:00:23 +0000

Tags:

Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ

amministratore — Thu, 10 Apr 2014 06:00:23 +0000

Tags:

Tamiflu and Relenza effectiveness questioned by Cochrane Collaboration and BMJ

amministratore — Thu, 10 Apr 2014 06:00:23 +0000

Tags:

Mutated strain of H7N9 flu virus developed drug resistance

amministratore — Wed, 11 Dec 2013 10:31:54 +0000

A strain of the emergent avian influenza A(H7N9) virus, which is now circulating in China, has developed some kind of resistance to antiviral drugs without losing its virulence. These are the conclusion exposed in an article just published on Nature Communications by a group of researchers from the Icahn School of Medicine at Mount Sinai.

They found that some H7N9 clinical isolates had an amino acid substitution in the structure of the viral neuraminidase (NA), a membrane-expressed, glycosylated enzyme to which the haemagglutinin (HA) glycoprotein binds.

Tags:

H7N9

Antivirals

Avian/Bird Flu

Mutated strain of H7N9 flu virus developed drug resistance

amministratore — Wed, 11 Dec 2013 10:31:54 +0000

Tags:

H7N9

Antivirals

Avian/Bird Flu

Mutated strain of H7N9 flu virus developed drug resistance

amministratore — Wed, 11 Dec 2013 10:31:54 +0000

Tags:

H7N9

Antivirals

Avian/Bird Flu

Mutated strain of H7N9 flu virus developed drug resistance

amministratore — Wed, 11 Dec 2013 10:31:54 +0000

Tags:

H7N9

Antivirals

Avian/Bird Flu

Two antivirals protect monkeys from MERS infection

amministratore — Mon, 09 Sep 2013 09:59:29 +0000

Interferon-alpha 2b (IFN-α2b) and Ribavirin are two licensed antiviral drugs that protects monkeys from MERS virus, as reported by a research team from the National Institute of Allergy and Infectious Diseases, in cooperation with Canadian and French scientists.

The study, published in the September 8 edition of Nature Medicine, confirmed previous experiments that led to hypothesize that a combination of these two antivirals, routinely used together to treat viral diseases such as hepatitis C, could be effective against the novel β coronavirus that, so far, has caused 108 human cases of

Tags:

Antivirals

Two antivirals protect monkeys from MERS infection

amministratore — Mon, 09 Sep 2013 09:59:29 +0000

Tags:

Antivirals

Two antivirals protect monkeys from MERS infection

amministratore — Mon, 09 Sep 2013 09:59:29 +0000

Tags:

Antivirals